Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MAOMEI RUAN
RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma
Oncology Letters
Cancer Research
Oncology
Related publications
Serum Thyroglobulin Determination in the Follow-Up of Patients With Differentiated Thyroid Carcinoma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Serum Thyroglobulin in Differentiated Thyroid Cancer.
BMJ
Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Preoperative Serum Thyroglobulin Predicts Initial Distant Metastasis in Patients With Differentiated Thyroid Cancer
Scientific Reports
Multidisciplinary
Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer
Cancer
Cancer Research
Oncology
Multicentre Clinical Evaluation of the New Highly-Sensitive Elecsys® Thyroglobulin II Assay in Patients With Differentiated Thyroid Carcinoma
Clinical Endocrinology
Endocrinology
Metabolism
Diabetes
Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome)
International Journal of Otolaryngology and Head & Neck Surgery
